KEVORKIAN TO BE PAROLED
Convicted murderer and euthanasia activist Jack Kevorkian has been granted parole. He has promised not to participate in any more assisted suicides. Kevorkian was convicted in 1999 in Michigan of second-degree murder after helping a man with Lou Gehrig’s disease to die — a death which he videotaped and screened on the CBS show 60 Minutes. He claims to have helped at least 130 people to die.
“You can put any conditions you want on me,” he told the parole board. “I’m not going to do it again. Anything that will bring me back to prison I will avoid. Prison is not a place to live.” However, he will continue to press for the legalisation of assisted suicide. Kevorkian has served 8 years of a 10 to 25-year sentence; his parole begins in June.
Michael Cook edits BioEdge, a bioethics newsletter, and MercatorNet, an on-line magazine whose focus is human dignity. He writes from Sydney, Australia.
Latest posts by Michael Cook (see all)
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...
